Skip to main content

Herbal Extract

Sabroxy (Oroxylum indicum) Extract

Also known as: Oroxylum indicum bark extract, Oroxylin A extract, Shyonaka, Sabroxy®

D
Evidence

Sabroxy is a standardized extract from Oroxylum indicum bark containing oroxylin A, a flavonoid compound studied for potential neuroprotective and cognitive effects. Research is limited primarily to in vitro and animal models, with minimal human clinical data available.

Find the best Sabroxy (Oroxylum indicum) Extract supplements — free
See Sabroxy (Oroxylum indicum) Extract products scored on dose & form, then track your intake in the app.
Open app →

Primary uses

  • Cognitive support
  • Neuroprotection
  • Brain health
  • Antioxidant support

How it works

  • GABA receptor modulation (proposed)
  • Antioxidant activity via oroxylin A
  • Neuroprotective signaling pathways
  • Anti-inflammatory mechanisms

Dosage

Typical range
300-600 mg daily (based on traditional use and early studies)
Timing
Typically morning or divided doses
With food
No specific requirement; may be taken with or without food
Duration
Optimal duration of use not established; human studies lacking
Special populations
Safety in pregnant women, nursing mothers, and children not established; use with caution

Forms

  • Powder extract (10% oroxylin A standardization)· 70/100

Safety

Common side effects

  • Generally well-tolerated in limited human exposure
  • Potential headache or GI upset (anecdotal)
  • Insufficient data for comprehensive side effect profile

Contraindications

  • Pregnancy and breastfeeding (insufficient safety data)
  • Known hypersensitivity to Acanthaceae family plants

Products containing Sabroxy (Oroxylum indicum) Extract

Top-scoring supplements in our catalog that list Sabroxy (Oroxylum indicum) Extract on the label. Each product is graded on Formulate's ingredient-level rubric — dose accuracy, form, transparency, and third-party testing.

See all products →

Evidence notes

Evidence is primarily limited to in vitro studies and animal models. Oroxylin A shows promise in preclinical research but lacks adequate human clinical trials to establish efficacy or optimal dosing. No robust RCT data in human subjects currently available.

Grade D: Primarily pre-clinical or anecdotal; human efficacy not established.

Related in Herbal Extract

Check a full stack

Formulate's free interaction checker lets you paste in any combination of supplements and medications at once — every pairing flags severity, timing, and cited evidence.

Open the checker

Medical disclaimer. This page is educational and does not replace advice from a qualified healthcare provider.